Rare diseases
Investigational molecules
Locations
Back to Poland113 clinical trials in Koszalin, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of Camizestrant and CDK4/6 Inhibitor for Patients with Advanced Breast Cancer with ESR1 Mutation
PolandStudy on Patient Preference for Subcutaneous Pembrolizumab with Hyaluronidase vs. Intravenous Pembrolizumab in Melanoma, Renal Cell Carcinoma, and Lung Cancer Patients
PolandStudy of MK-7684A and Pembrolizumab for Patients with Advanced Solid Tumors
PolandStudy Comparing Radium-223 Dichloride with Abiraterone Acetate, Enzalutamide, and Prednisone in Patients with Advanced Prostate Cancer Spread to the Bone
PolandStudy on Durvalumab with Oleclumab or Monalizumab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy
PolandStudy on Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis
PolandStudy of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression
PolandStudy on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer
PolandStudy on the Effectiveness and Safety of Durvalumab with Gemcitabine and Cisplatin for Patients with Muscle-Invasive Bladder Cancer
PolandStudy on Nivolumab and Ipilimumab for Patients with Untreated Unresectable or Metastatic Urothelial Cancer
PolandStudy Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment
PolandStudy of V940 and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on bladder cancer and prostate cancer treatments, including combination therapies with immunological agents and targeted treatments.
Studies evaluating durvalumab, BCG combinations, and hormone therapy approaches for improved patient outcomes.
Advanced studies in gastric cancer and gastroesophageal junction cancers, focusing on targeted therapies and immunotherapy combinations.
Investigating trastuzumab deruxtecan and other innovative treatment combinations for metastatic disease.
Comprehensive research in non-small cell lung cancer, exploring novel drug combinations and immunotherapy approaches.
Evaluating new therapeutic options including pembrolizumab combinations and investigational agents.
Pioneering research in advanced breast cancer treatment, particularly focusing on hormone receptor-positive, HER2-negative disease.
Studies exploring new treatment combinations with CDK4/6 inhibitors and hormone therapy.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
